Dow Down 1.40% Nasdaq Down 1.59%

Alkermes plc (ALKS)

-NasdaqGS
41.47 Down 1.40(3.27%) Oct 1, 4:00PM EDT
|After Hours : 41.47 0.00 (0.00%) Oct 1, 4:36PM EDT
Prev Close:42.87
Open:42.59
Bid:37.73 x 600
Ask:51.48 x 100
1y Target Est:50.92
Beta:1.57
Earnings Date:Oct 27 - Oct 31 (Est.)
Day's Range:41.01 - 42.86
52wk Range:29.36 - 54.25
Volume:845,965
Avg Vol (3m):761,626
Market Cap:6.05B
P/E (ttm):N/A
EPS (ttm):-0.05
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALKS

Comparison

Symbol% ChgMkt Cap
ALKSDown 3.27%6.05B
ABTDown 0.99%61.92B
LLYUp 0.35%69.75B
GSKDown 0.15%110.25B

Key Statistics

Forward P/E (1 yr):69.12
P/S (ttm):11.19
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.27
Quarterly EPS Est (Sep-14) :0.02
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):11.64

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alkermes Public Limited Company, an integrated biopharmaceutical company, develops medicines that enhance patient outcomes. The company offers RISPERDAL CONSTA for schizophrenia and bipolar I disorder; INVEGA SUSTENNA to treat schizophrenia; AMPYR... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback